CN Patent

CN103006661B — 一种含有盐酸鲁拉西酮的制剂及其制备方法

Assigned to NANJING HAILING PHARMACEUTICAL CO Ltd OF YANGTZE RIVER PHARMACEUTICAL GROUP · Expires 2015-02-18 · 11y expired

What this patent protects

本发明涉及一种口服制剂及制备方法，该制剂含有盐酸鲁拉西酮与分散载体的微粉化颗粒、微晶纤维素和水溶性聚合物粘合剂，更具体地，本发明涉及口服制剂，特别是片剂，该制剂具有较快的溶出特性，并具有相同的活性成分溶出特性，即使其活性成分的含量在一定范围内发生变化时也是如此。

USPTO Abstract

本发明涉及一种口服制剂及制备方法，该制剂含有盐酸鲁拉西酮与分散载体的微粉化颗粒、微晶纤维素和水溶性聚合物粘合剂，更具体地，本发明涉及口服制剂，特别是片剂，该制剂具有较快的溶出特性，并具有相同的活性成分溶出特性，即使其活性成分的含量在一定范围内发生变化时也是如此。

Drugs covered by this patent

Patent Metadata

Patent number
CN103006661B
Jurisdiction
CN
Classification
—
Expires
2015-02-18
Drug substance claim
No
Drug product claim
No
Assignee
NANJING HAILING PHARMACEUTICAL CO Ltd OF YANGTZE RIVER PHARMACEUTICAL GROUP
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.